BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia - Wikidata - awgldk - TriplyDB

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia

http://www.wikidata.org/entity/Q37434990

about

Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia.Mitochondrial priming of chronic lymphocytic leukemia patients associates Bcl-xL dependence with alvocidib response.SORTCERY-A High-Throughput Method to Affinity Rank Peptide Ligands.BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells.Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells Recent discoveries in molecular characterization of acute myeloid leukemia.Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome.Combined venetoclax and alvocidib in acute myeloid leukemia.MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.CDK9 inhibitors in acute myeloid leukemia.

P2860

Q28548058-41B3B68E-7419-43A9-BC5F-B7805FD8FB6E Q30398758-97152280-5D99-4819-B027-D9E54A319B19 Q33702409-8898A212-8692-4DA6-9247-3CB8BB76EF2B Q33925386-AF51F5A8-FF14-40F9-93F1-4EB531861477 Q34458745-0EC034F4-6C2E-49FE-B548-FC7E4780FBE7 Q35328717-C41CC5B6-3C1B-4D74-A9CB-4070135F1990 Q35641404-33EA2E99-DF94-48D0-9356-68B48B875B9F Q36003724-95E343E6-DD70-438F-AAEB-FDA9C03DC2FF Q37725409-CDA7ACB1-2E59-44CF-980F-8A93A8F0F543 Q38194465-3655D28E-6E11-4D56-8090-117F864B0FD9 Q40139200-5F20663B-6C37-481C-8FB0-34F3CD438069 Q47105216-767620A1-F3C2-4F4F-880A-4364D074CC87 Q50066248-02D7B86C-C3AC-4748-80D7-69DAB25668AA Q50318294-59FBE50E-A7E1-4738-BA5F-D37F7FAA353F

P2860

BH3 profiling discriminates response to cytarabine-based treatment of acute myelogenous leukemia

http://www.wikidata.org/entity/Q37434990

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

BH3 profiling discriminates re ...... of acute myelogenous leukemia

@en

BH3 profiling discriminates re ...... of acute myelogenous leukemia.

@nl

type

label

BH3 profiling discriminates re ...... of acute myelogenous leukemia

@en

BH3 profiling discriminates re ...... of acute myelogenous leukemia.

@nl

prefLabel

BH3 profiling discriminates re ...... of acute myelogenous leukemia

@en

BH3 profiling discriminates re ...... of acute myelogenous leukemia.

@nl

P1433

Q37434990-5450A157-655F-42B9-8A5C-A25DDA551B11

P1476

Q37434990-3F1CCCE6-CCF2-47F6-86BC-1422E875C0C2

P2093

Q37434990-225EF474-A7E3-4E29-AD15-68B78CFD8FF9

Q37434990-421261A6-8EDA-453F-B15C-91EC0839D020

Q37434990-855F2951-4950-41DA-8BA6-379B84618162

Q37434990-934D2C1F-DA99-44C4-9D3C-C4CD6C49A0B3

Q37434990-A377F989-CAFE-4114-B356-21EDD49BEEDA

Q37434990-E4C2AEE6-3D9F-419A-B569-BB49496555DC

P2860

Q37434990-01B39402-9D52-4F46-8A11-08002EEF83C6

Q37434990-051E6DAB-91F5-4D38-BCAF-9DE8FB1E25E3

Q37434990-0E868FCF-B540-484F-B0B0-494BF24C1C95

Q37434990-224CD1BF-161A-449C-AD3D-9466B4DB19FA

Q37434990-2846EB41-CDBC-482E-ADDE-B41CC1FC8842

Q37434990-28A99B42-4684-4115-983F-6BD2515E9226

Q37434990-2FD4A747-9FCF-4B94-B87D-DF6D5BAD7D86

Q37434990-32FD410E-7C60-460D-8B0B-29E63FCEDA74

Q37434990-35063867-39F8-4461-9088-93E0627BED7C

Q37434990-35EA8BB0-F8D0-4DFA-A172-AD2FBB28CDDD

P304

Q37434990-DB6C6090-C9FE-4149-B5F2-6709EC3163A8

P31

Q37434990-84FED45E-B001-4EDB-B336-41F13EDCE583

P356

Q37434990-391BC39A-9800-4254-A28D-4100E80180E2

P433

Q37434990-10D9265A-845B-4994-A9D6-E756ECEF50D5

P478

Q37434990-134A0DEE-E066-43CD-8D4C-1DDB07109811

P50

Q37434990-26e6e0eb-4f3e-f973-4a4f-47b94e1387b7

Q37434990-7A26A68D-AACF-44BE-99EB-5A4C879090DC

Q37434990-CB996D46-03B6-47EA-870A-F55CA77706CC

Q37434990-D33A61D9-8376-4685-BF78-4E8CEA96A299

P577

Q37434990-549B8268-5734-4483-A253-94B53F5D57F7

P698

Q37434990-F88E65F1-7893-429A-9A21-7574EA962B50

P921

Q37434990-511B6D2E-CD82-4851-B2AC-79F0D01F6A61

P932

Q37434990-833F5B9E-9C3D-4ABD-A114-FAA9F2BCAEB5

P356

1535-7163.MCT-13-0692

P1433

Molecular Cancer Therapeutics

P1476

BH3 profiling discriminates re ...... of acute myelogenous leukemia

@en

P2093

Michael H Cardone

http://www.w3.org/2001/XMLSchema#string

Nicole E Carlson

http://www.w3.org/2001/XMLSchema#string

Noel Blake

http://www.w3.org/2001/XMLSchema#string

Steven M Kornblau

http://www.w3.org/2001/XMLSchema#string

William E Pierceall

http://www.w3.org/2001/XMLSchema#string

Xuelin Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review

The treatment of adult acute myeloid leukemia

Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.

Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).

Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes.

Functional proteomic profiling of AML predicts response and survival

MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

P304

2940-2949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-13-0692

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Marina Konopleva

Michael Andreeff

Michael Elashoff

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24092807

http://www.w3.org/2001/XMLSchema#string

P921

P932

3881173

http://www.w3.org/2001/XMLSchema#string